Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma
Asher Chanan‐Khan, Sagar Lonial, Donna Weber, Ivan Borrello, Robin Foà, Andrzej Hellmann, Meletios A Dimopoulos, Arlene S. Swern, Robert Knight (2012). Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma. , 96(2), DOI: https://doi.org/10.1007/s12185-012-1125-7.
